行动呼吁:消除黑人小细胞肺癌临床前研究与临床诊疗中的种族不公
本文聚焦黑人小细胞肺癌(SCLC)患者,指出初步数据显示黑人SCLC发病风险可能低于白人,但该差异机制未明且需更大数据集验证。黑人SCLC生物学信息匮乏、多样化祖先来源的临床前模型稀少,且临床试验中黑人受试者数量显著偏低,不同社区间诊疗也存在差异。作者呼吁深入研究遗传、环境和社会经济因素对SCLC发生、临床前研究、临床诊疗及结局的影响。
要点
- 初步数据显示黑人SCLC发病风险可能低于白人,但需更大数据集验证。
- 黑人SCLC生物学信息及多样化祖先来源的临床前模型严重匮乏。
- SCLC新药临床试验中黑人受试者数量显著偏低,诊疗可能存在社区差异。
核心结论
- 需要更深入研究与SCLC发生、临床前研究、临床诊疗及结局相关的遗传、环境和社会经济因素。
主要发现
- 与白人相比,初步数据显示黑人个体SCLC发病风险可能更低,但该差异仍未解释且需在更大数据集中验证。
- 黑人SCLC的生物学信息很少,实验室中来自不同祖先背景的患者来源临床前SCLC模型很少。
- 测试SCLC新疗法的临床试验中黑人参与者数量显著偏低。
- 有证据表明黑人患者比例高的社区与无此类特征的社区之间SCLC患者诊疗可能存在差异。
临床怎么用
- 在临床前研究中应纳入多样化祖先来源的SCLC模型以反映黑人患者生物学特征。
- 开展SCLC临床试验时应着力提高黑人受试者的代表性。
- 临床诊疗中需关注黑人患者比例高的社区可能存在的诊疗差异。
局限性
- 黑人SCLC发病风险较低的初步发现仍需在更大数据集中验证。
- 黑人SCLC的生物学信息及多样化祖先来源的临床前模型均很有限。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Small cell lung cancer (SCLC) is an aggressive disease with dismal survival rates and limited therapeutic options. SCLC development is strongly associated with exposure to tobacco carcinogens. However, additional genetic and environmental risk factors that contribute to SCLC pathogenesis are beginning to emerge. Here, we specifically assess disparities pertaining to SCLC in Black populations. In contrast to non-small cell lung cancer, preliminary data suggest that Black individuals may actually be at a lower risk of developing SCLC relative to white individuals. This difference remains unexplained but urgently needs to be verified in larger data sets, because it could provide important new insights and approaches to understanding this recalcitrant tumor. Importantly, little biological information exists on SCLC in Black individuals, and few patient-derived preclinical SCLC models from diverse ancestries are available in the laboratory. Unfortunately, we note strikingly low numbers of Black participants in clinical trials testing new treatments for SCLC. Evidence further indicates that care for patients with SCLC may vary between communities with a large fraction of Black patients and those without. Together, these observations underscore the need to better investigate genetic, environmental, and socioeconomic factors associated with SCLC development, preclinical research, clinical care, and outcomes.
引用
- Thomas PL, Madubata CJ, Aldrich MC, et al. A Call to Action: Dismantling Racial Injustices in Preclinical Research and Clinical Care of Black Patients Living with Small Cell Lung Cancer. Cancer Discov. 2020. PMID: 33318034. doi:10.1158/2159-8290.CD-20-1592
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。